Christopher McGuinness
Directeur/Membre du Conseil chez Watchmaker Genomics, Inc.
Profil
Chris currently serves as the Chief Operating Office of Kapa Biosystems.
He spent much of his career as a project manager and entrepreneur in the telecommunications field.
Chris was a founder of ECHO, a broadband network engineering firm, which was purchased by Keppel Communications in 2003.
Chris holds a BS in Physics from Emory University and an MBA, with a focus in finance, from The University of Chicago School of Business.
Chris is an investment committee member of Table Mountain Capital, LLC and managing member of McGuinness Investments LLC.
Postes actifs de Christopher McGuinness
| Sociétés | Poste | Début |
|---|---|---|
Table Mountain Capital LLC
 Table Mountain Capital LLC Investment ManagersFinance Table Mountain Capital LLC (Table Mountain Capital) is a venture capital firm founded in 2006. The firm is headquartered in Boulder, Colorado. | Private Equity Investor | - |
Watchmaker Genomics, Inc.
 Watchmaker Genomics, Inc. BiotechnologyHealth Technology Watchmaker Genomics, Inc. applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. Based in Boulder, CO, the Watchmaker team brings decades of collective experience building successful life science companies, commercializing novel technologies, and advancing clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. Watchmaker partners directly with innovative life science companies, commercial sequencing providers, and pioneering research labs. The CEO of the company is John F. Foskett. | Directeur/Membre du Conseil | - |
Anciens postes connus de Christopher McGuinness
| Sociétés | Poste | Fin |
|---|---|---|
Kapa Biosystems, Inc.
 Kapa Biosystems, Inc. BiotechnologyHealth Technology Kapa Biosystems, Inc. provides genomic tools. It develops solutions that accelerate genomics research to diagnose, monitor, and treat cancer and complex inherited and infectious diseases. The company was founded by John Foskett, Paul McEwan, Ron McEwan, and Christopher McGuinness in 2006 and is headquartered in Wilmington, MA. | Fondateur | 01/09/2016 |
| Echo Networks | Fondateur | 31/12/2002 |
Formation de Christopher McGuinness
| Emory University | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kapa Biosystems, Inc.
Kapa Biosystems, Inc. BiotechnologyHealth Technology Kapa Biosystems, Inc. provides genomic tools. It develops solutions that accelerate genomics research to diagnose, monitor, and treat cancer and complex inherited and infectious diseases. The company was founded by John Foskett, Paul McEwan, Ron McEwan, and Christopher McGuinness in 2006 and is headquartered in Wilmington, MA. | Health Technology |
| Echo Networks | |
Table Mountain Capital LLC
Table Mountain Capital LLC Investment ManagersFinance Table Mountain Capital LLC (Table Mountain Capital) is a venture capital firm founded in 2006. The firm is headquartered in Boulder, Colorado. | Finance |
Watchmaker Genomics, Inc.
Watchmaker Genomics, Inc. BiotechnologyHealth Technology Watchmaker Genomics, Inc. applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. Based in Boulder, CO, the Watchmaker team brings decades of collective experience building successful life science companies, commercializing novel technologies, and advancing clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. Watchmaker partners directly with innovative life science companies, commercial sequencing providers, and pioneering research labs. The CEO of the company is John F. Foskett. | Health Technology |
